| VANDA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US9216591084 / A0JJT3 |
| VM4 (Frankfurt) / VNDA (NASDAQ) |
| FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA |
| - |
| https://www.vandapharma.c.. |
|
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness,..
>Volltext.. |
| 352.81 Mio. EUR |
| 141.33 Mio. EUR |
| 185.07 Mio. EUR |
| -119.25 Mio. EUR |
| -188.81 Mio. EUR |
| -3.2 EUR |
| 10.81 Mio. EUR |
| 72.75 Mio. EUR |
| -93.72 Mio. EUR |
| 1.82 |
| -4.17% |
| -928.19% |
| - |
| - |
| - |
| - |
| VANDA |
| 08.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|